Andrea Califano, Ph.D.
Dr. Califano is Professor of Systems Biology, in the departments of Biochemistry and Molecular Biophysics, of Biomedical Informatics, and in the Institute for Cancer Genetics at Columbia University. He is currently the funding director and chair of the Columbia Initiative for Systems Biology, which includes the Sulzberger Columbia Genome Center and the Center for Computational Biology and Bioinformatics. He also serves as Associate Director for Bioinformatics in the Herbert Irving Comprehensive Cancer Center. Dr. Califano serves on numerous editorial and scientific advisory boards, including the Board of Scientific Advisors of the National Cancer Institute. Dr. Califano received his doctoral degree from the University of Florence in 1985. Dr. Califano’s lab, which integrates both experimental and computational research, has pioneered a variety of algorithms for the dissection of transcriptional, post-transcriptional, and post-translational regulatory interactions in mammalian cells and for their interrogation to identify master regulators of aberrant transformation and physiological differentiation/maturation events. The Califano lab has published the first genome-wide regulatory networks for normal and tumor-related human cells, including neoplastic malignancies of lymphoma and glioma subtypes.
Timothy A. Chan, M.D., Ph.D.
Dr. Chan is a member of Memorial Sloan-Kettering Cancer Center’s central nervous system disease-management team and of the Brain Tumor Center. He is a board certified radiation oncologist specializing in the use of stereotactic radiosurgery, intensity modulated radiation therapy and conformal radiation therapy. In addition to treating patients, Dr. Chan is a Principal Investigator at a cancer genetics laboratory in the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, which is focused on the genetics of cancer and using its findings on the cancer genome to develop better diagnostic and treatment approaches that will improve the care of cancer patients.
Riccardo Dalla-Favera, M.D.
Dr. Dalla-Favera is the Director of the Institute for Cancer Genetics at Columbia University and the Percy and Joanne Uris Professor of Pathology and Genetics and Development (Columbia University Medical School), in addition to serving as the Director of the Institute for Cancer Research at Columbia University. He currently is a member of the Scientific Advisory Boards of the Yale Cancer Center of the Albert Einstein College of Medicine Cancer Center and of the Lymphoma Research Foundation.
Hans-Guido Wendel, M.D.
Dr. Wendel is a Principal Investigator at the Cancer Genetics Laboratory at Memorial Sloan-Kettering Cancer Center, which is focused on the genetics of cancer and using its findings on the cancer genome to develop better diagnostic and treatment approaches that will improve the care of cancer patients. His research is focused on modeling relevant genetic changes found in human cancer specimens in cell culture and in accurate mouse models, in particular, using the technique of adoptive transfer of retrovirally transduced hematopoietic stem cells.
Vundavalli V. Murty, Ph.D.
Dr. Murty is currently Director of the Cancer Cytogenetic Laboratory and Molecular Pathology at Columbia University. He is an Associate Editor of the journal Molecular Cancer and a Diplomate of the American Board of medical Genetics in the subspecialty, Clinical Cytogenetics. Dr. Murty has authored over 100 original research papers, book chapters, and reviews covering human and murine cancers. Dr. Murty’s laboratory investigates the genetic mechanisms involved in testicular germ cell tumor and cervical cancer
Charles M. Rudin, M.D., Ph.D.
Dr. Charles Rudin is the Chief of the Thoracic Oncology Service at Memorial Slone Kettering Cancer Center specializing in the care of patients with lung cancer. Dr. Rudin directs both laboratory-based and clinical research with the goal of improving the outcome for patients with lung cancer. In addition to serving as Chief of the Thoracic Oncology Service at MSKCC, Dr. Rudin co-chairs the Eastern Cooperative Oncology Group Thoracic Committee and is a member of the National Cancer Institute Thoracic Malignancies Steering Committee.